A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 38/24 (2006.01)
Patent
CA 2588837
The compositions and methods disclosed herein are for prevention or treatment of multi-organ failure with erythropoietin. The usefulness of the present invention is that erythropoietin may act to prevent the onset of MOF in a patient at risk of developing it. The present invention may further lessen the effect in one or more affected organs in a patient at risk of developing MOF or in one already diagnosed with it.
Les compositions et procédés de l'invention sont destinés à la prévention ou au traitement du syndrome de défaillance multiviscérale avec l'érythropoïétine. L'utilité de l'invention est que l'érythropoïétine peut agir de façon à prévenir la survenue du syndrome de défaillance multiviscérale chez un sujet à risque. L'invention peut en outre atténuer les effets au niveau de l'un au moins des organes affectés chez un sujet à risque ou chez qui le syndrome a déjà été diagnostiqué.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
University Of Utah Research Foundation
LandOfFree
Erythropoietin for treatment of multi-organ failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythropoietin for treatment of multi-organ failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin for treatment of multi-organ failure will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1848747